Description
Selenyx™ Selank is a high-purity research-grade neuropeptide formulated for advanced studies in cognitive modulation, emotional regulation, and neurochemical signaling. Selank is known for its interaction with inhibitory and excitatory neurotransmitter systems, making it a valuable compound for investigating stress-response pathways, synaptic plasticity, and central nervous system stability. Its standardized 10mg/mL concentration supports precision-driven experimental protocols in neuroscience and behavioral research.
Benefits
-
Supports cognitive function research
-
Facilitates emotional regulation studies
-
Aids investigation of stress-response pathways
-
Supports GABAergic and serotonergic signaling analysis
-
Contributes to neuroplasticity research
-
Enables behavioral neuroscience modeling
-
Supports CNS homeostasis studies
-
Facilitates neurochemical balance research
-
Enhances learning and memory pathway investigations
-
Supports mental performance research frameworks
Scientific Areas of Study
Cognitive Neuroscience:
Studied for its role in memory, attention, and learning modulation.
Stress and Anxiety Models:
Investigated for its effects on stress signaling and emotional adaptation pathways.
Neurotransmitter Systems:
Applied in research focusing on GABA, serotonin, and dopaminergic pathway modulation.
Neuroplasticity:
Used in studies exploring synaptic remodeling and neural adaptability.
Behavioral Research:
Supports experimental models in performance, focus, and emotional resilience.
Research Conclusion
Selenyx™ Selank (10mg/mL) is a high-purity synthetic neuropeptide designed for precision research in cognitive enhancement pathways, stress-response regulation, and neurochemical signaling. Its molecular stability and standardized formulation make it a reliable research tool for advanced neuroscience, behavioral science, and neuroendocrine laboratory programs conducted under controlled experimental conditions. This product is strictly intended for research use only.


Reviews
There are no reviews yet.